Novartis Says Closely Watched Cholesterol Study Failed to Meet Goal

Date:




The Phase 3 study found a drug didn’t reduce the risk of cardiovascular events like heart attacks and strokes.



Source link

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

News Quiz for September 5, 2026

News Quiz for September 5, 2026 Source link

Transfer rumors, news: Arsenal set to sign teenage Georgian midfielder

The transfer window may be over, but that hasn't...

New Hampshire man describes animal attack seen in viral video

'He's got bigger issues than I've got right now':...